Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 72 results for "biotechnology regulatory authority of..."

Developments in Bio-Technology Sector

India's research performance in Pharmacology and Biotechnology indicates that India's scholarly output based on publication data is nearly 5 % of the world's total in 2014 and showing strong average growth of over 12 % annually. Shri Y.S. Chowdary, ... Press Information Bureau, 3 weeks ago

3 images for "biotechnology regulatory authority of india b"

Media Nama, 2 months ago
Indian Express, 6 months ago, 7 months ago

Indian Government Amends Foreign Direct Investment Policy (July 2016)

The Foreign Direct Investment Policy (" FDI Policy ") is the primary regulation governing foreign investment in India. The Government of India (" Government ") introduced several amendments to the FDI Policy through the annual Consolidated Foreign ...
 Gibson Dunn1 month ago

First Indian Pharmacovigilance Day conference to be held in Mumbai

The first Indian Pharmacovigilance Day conference will be held in Mumbai on July 29, 2016. Dr J Vijay Venkatraman, Managing Director and Chief Executive Officer of Oviya MedSafe, a global pharmacovigilance consulting and drug safety services, will ...
 CPhI.cn4 weeks ago Dr J Vijay Venkatraman to chair first Indian Pharmacovigilance Day conference on July 29 at Mumbai  PharmaBiz4 weeks ago Indian Pharmacovigilance Day 2016 to be observed in Mumbai on July 29  PharmaBiz2 months ago

Takeda and Seattle Genetics Announce Positive Data from Phase 3 ALCANZA Clinical Trial of ADCETRIS® Brentuximab Vedotin for CD30 Expressing Cutaneous T Cell Lymphoma

Few Sec ago Business Wire India Takeda Pharmaceutical Company Limited (TSE:4502) and Seattle Genetics, Inc. (NASDAQ:SGEN) today announced that the Phase 3 ALCANZA clinical trial evaluating ADCETRIS (brentuximab vedotin) in patients with ...
 India Online.in3 weeks ago Seattle Genetics and Takeda Announce Publication of Final Data from ADCETRIS® Brentuximab Vedotin Monotherapy Pivotal Phase 2 Clinical Trial in Relapsed or Refractory Classical Hodgkin Lymphoma in Blood  India Online.in1 month ago

Eurofins Scientific: Growth Momentum Sustained as Strong Q1 Operating Trends Continued in Q2 2016

LUXEMBOURG--( BUSINESS WIRE )--Regulatory News: Eurofins Scientific (Paris:ERF): Revenues of EUR 1,208m in H1 2016 represent a 43.5% increase over the same period in the previous year. Organic growth 9 during the period was over 11%, the ...
 Business Wire3 weeks ago Growth momentum sustained as strong Q1 operating trends continued in Q2 2016  Eurofins Scientific3 weeks ago

Ipsen's First Half 2016 Results

PARIS--( BUSINESS WIRE )--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven pharmaceutical group, today announced financial results for the first half 2016. The Board of Directors, chaired by Marc de Garidel, met on ...
 Business Wire3 weeks ago Ipsen 's First Half 2016 Results  Stockwatch3 weeks ago

Harmonisation in ASEAN

Upcoming SlideShare Loading in … 5 1. Harmonisation of Food Standards in ASEAN A Shared Vision For Regulatory Convergence FIA Executive Summary 2. Contents Introduction to This Guide Foreword by FIA President ASEAN and the Agro-food ...
 SlideShare.net3 weeks ago
Free Malaysia Today

China's Fosun to buy Indian drugmaker for US$1.26b

A company logo of Fosun International is seen during the annual general meeting of the Chinese conglomerate, founded by billionaire Guo Guangchang, in Hong Kong, China in this May 28, 2015 file photo. — Reuters pic HONG KONG, July 29 — The ...
 Malay Mail3 weeks ago

GM crops: rebuttal of claims on safety and benefits

1. GMO foods and crops pose health risks Scientific organisations Stijn Bruers' article starts with an appeal to authority in claiming GMOs are safe, that doesn't stand up to scrutiny. He cites a number of respected scientific organisations, ...
 Corporate Europe Observatory1 month ago

Forget Pharmaceuticals Think Immunology and Synthetic Biology

As seen in the latest issue of Master Investor Magazine Investors often suppose that biotechnology is all about the development of new wonder drugs which zap bacteria and viruses pharmacology. But in fact the best investment prospects probably ...
 Master Investor1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - biotechnology regulatory authority of india b
Get updated on latest news & your favorite topics right in your inbox!
More     Less